New indolizine–chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation

A new family of indolizine–chalcones was designed, synthesized and screened for the inhibitory potential on human farnesyltransferase in vitro to identify potent antitumor agents. The most active compound was phenothiazine 2a, exhibiting an IC50 value in the low nanomolar range, similar to that of known FTI-276, highly potent farnesyltransferase inhibitor. The newly synthesized indolizine–chalcones 2a–d constitute the most efficient inhibitors of farnesyltransferase bearing a phenothiazine unit known to date.

Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide